• Home
  • Media Center
  • Press Center
  • Company News

Company News

Investor Relations

Samsung Biologics records annual sales of KRW 535.8 billion and Operating Profit 55.7 billion in 2018

?

Samsung Biologics records annual sales of KRW 535.8 billion and Operating Profit 55.7 billion in 2018

 

‘19. 01. 31(Thurs)

 

Incheon, South Korea, January 31st, Samsung Biologics (CEO: Tae Han Kim) today announced its business performance for 2018. The company posted that it had recorded annual sales of KRW 535.8 billion, operating profit of KRW 55.7 billion, and net profit of KRW 224.1 billion. 
 
Sales increased by KRW 71.2 billion (+15.3%) due to increase of capacity utilization in Plant No. 2. Operating profit fell by KRW 10.3 billion (-15.6%) due to depreciation cost from Plant No. 3 operation and an increase in SG&A expenses.

 

Net profit increased by KRW 321.1 billion YOY due to cash inflows from the asset transfer deal with Biogen in November of last year.

 

Samsung Biologics transferred 9,226,068 Samsung BioEpis shares to Biogen and paid KRW 759.5 billion in cash as Biogen exercised the call option last year.

 

As a result, the assets to be held for disposal and derivative liabilities that were reflected in the existing financial statements were both removed and the final difference of KRW 389.2 billion has been reflected in non-operating income in the Q4 of 2018.

 

In addition, the debt-to-equity ratio, which was 81% at the end of 2017, dropped to 44% by the end of 2018 due to the removal of derivatives liabilities resulting from the call option. Cash assets amounted to about KRW 1,100 billion at the end of 2018 from KRW 350 billion at the end of 2017.

 

※ Samsung Biologics Financial Result 2018      (Billion KRW)

 

 2018

 2017

 YoY

 Sales

 535.8

 464.6

 +71.2(+15.3%)

 Operating Profit

 55.7

 66

 -10.3(-15.6%)

 Net Profit

 224.1

 -97

 +321.1

(Turn into profit-making)

 Liabilities
(ratio)

 1,824.9
(44%)

 3,200.6
(81%)

 -1,381.7(+36.7%)

 

 

Sales in the fourth quarter were KRW 178.3 billion, an increase of KRW 77.2 billion (76.4%) from the previous quarter due to increased product shipments. However, operating profit recorded KRW 11.5 billion (9.5%), an increase of KRW 1 billion due to depreciation in Plant No. 3 and increase in commission fees.

 

Net profit was KRW 317.3 billion, an increase of KRW 347.4 billion due to the close of the asset transfer with Biogen.

 

Meanwhile, Samsung Biologics announced that it had received a total of 45 product manufacturing contracts from 25 companies and the company is targeting for more than 12 CMO and 10 CRO/CDO orders by the end of this year.

 

The company also announced that it plans to raise orders for Plant No. 3 ? which currently secured 25% of total production capacity ? to 50 % by the end of the year.

? 

Samsung Biologics records annual sales of KRW 535.8 billion and Operating Profit 55.7 billion in 2018

 

‘19. 01. 31(Thurs)

 

Incheon, South Korea, January 31st, Samsung Biologics (CEO: Tae Han Kim) today announced its business performance for 2018. The company posted that it had recorded annual sales of KRW 535.8 billion, operating profit of KRW 55.7 billion, and net profit of KRW 224.1 billion.  
 
Sales increased by KRW 71.2 billion (+15.3%) due to increase of capacity utilization in Plant No. 2. Operating profit fell by KRW 10.3 billion (-15.6%) due to depreciation cost from Plant No. 3 operation and an increase in SG&A expenses.

 

Net profit increased by KRW 321.1 billion YOY due to cash inflows from the asset transfer deal with Biogen in November of last year.

 

Samsung Biologics transferred 9,226,068 Samsung BioEpis shares to Biogen and paid KRW 759.5 billion in cash as Biogen exercised the call option last year.

 

As a result, the assets to be held for disposal and derivative liabilities that were reflected in the existing financial statements were both removed and the final difference of KRW 389.2 billion has been reflected in non-operating income in the Q4 of 2018.

 

In addition, the debt-to-equity ratio, which was 81% at the end of 2017, dropped to 44% by the end of 2018 due to the removal of derivatives liabilities resulting from the call option. Cash assets amounted to about KRW 1,100 billion at the end of 2018 from KRW 350 billion at the end of 2017.

 

※ Samsung Biologics Financial Result 2018      (Billion KRW)

 

 2018

 2017

 YoY

 Sales

 535.8

 464.6

 +71.2(+15.3%)

 Operating Profit

 55.7

 66

 -10.3(-15.6%)

 Net Profit

 224.1

 -97

 +321.1

(Turn into profit-making)

 Liabilities
(ratio)

 1,824.9
(44%)

 3,200.6
(81%)

 -1,381.7(+36.7%)

 

 

Sales in the fourth quarter were KRW 178.3 billion, an increase of KRW 77.2 billion (76.4%) from the previous quarter due to increased product shipments. However, operating profit recorded KRW 11.5 billion (9.5%), an increase of KRW 1 billion due to depreciation in Plant No. 3 and increase in commission fees.

 

Net profit was KRW 317.3 billion, an increase of KRW 347.4 billion due to the close of the asset transfer with Biogen.

 

Meanwhile, Samsung Biologics announced that it had received a total of 45 product manufacturing contracts from 25 companies and the company is targeting for more than 12 CMO and 10 CRO/CDO orders by the end of this year.

 

The company also announced that it plans to raise orders for Plant No. 3 – which currently secured 25% of total production capacity – to 50 % by the end of the year.

 

SITE MAP

close
close

Samsung Biologics
Privacy Policy

초점받기 링크
Effective Date: [30Dec2019]

This Privacy Policy illustrates how Samsung Biologics ("we", “our”, “us”) use and protect information you provide through your use of this website (the "Website") or our customer inquiry and recruitment services (collectively the “Services”).

Please read this Privacy Policy carefully and feel free to contact us if you have any questions, using the contact information provided in the Contact Us section below.

Information we may collect from you
1.Customer Inquiry

When you fill out the “Contact Us Form” on our Website, we may collect the following types of information:

  • Customer Inquiry information include Category, Information we may collect from you.
    Category Information we may collect from you
    Contact Us Mandatory Name, E-mail Address, Company Name, Occupation, Country, Areas of Interest, Inquiries/Comments
    Optional Any additional information you provide including but not limited to the job title
    Customer Inquiry information include Category, Information we may collect from you.
    Category Information we may collect from you
    Contact Us Mandatory Name, E-mail Address, Company Name, Occupation, Country, Areas of Interest, Inquiries/Comments
    Optional Any additional information you provide including but not limited to the job title

    Access log and website usage information collected through cookies. For more information about how we use cookies on our Website, please see our Cookie Policy.

2.Recruitment

When you submit your application via “TalentPool” on our Website, we may collect the following types of information:

  • Recruitment infomation include Category, Information we may collect from you.
    Category Information we may collect from you
    Talent Pool Mandatory Name, E-mail Address, Country, Areas of Interest, Resume
    Optional Any additional information you provide including but not limited to personal profiles on SNS
    Application Form
    (in Korean)
    Mandatory Name, Date of Birth, Address, E-mail, Contact Number,
    Education History (Name of School, Major, Enrollment Year/Month, Graduation Year/Month, Location), Employment History (Employment Period, Company, Job Title, Job Scope, Major Task), Language, Miscellaneous (Military Status, Reason for Exemption, Veteran Status)
    Optional Any additional information you provide including but not limited to research career, special qualifications and licenses, personal profiles on SNS.
    Recruitment infomation include Category, Information we may collect from you.
    Category Information we may collect from you
    Talent Pool Mandatory Name, E-mail Address, Country, Areas of Interest, Resume
    Optional Any additional information you provide including but not limited to personal profiles on SNS
    Application Form
    (in Korean)
    Mandatory Name, Date of Birth, Address, E-mail, Contact Number,
    Education History (Name of School, Major, Enrollment Year/Month, Graduation Year/Month, Location), Employment History (Employment Period, Company, Job Title, Job Scope, Major Task), Language, Miscellaneous (Military Status, Reason for Exemption, Veteran Status)
    Optional Any additional information you provide including but not limited to research career, special qualifications and licenses, personal profiles on SNS.

*No sensitive information will be collected.

How we use your information
1.Customer Inquiry

We may use the information we collect from you to conduct certain services or activities such as replying to inquiries, maintaining business records, and conducting market research.

2.Recruitment

In order to proceed with recruitment process and communicate status/result of job application(s).

Sharing information with third parties

We will not disclose your information to third parties for their marketing or business purposes without your consent. However, notwithstanding the above, we may disclose your information to the following entities for recruitment purposes:

  • Educational institutions in your application.
    Your information (name, date of birth, major, admission year, graduation year, etc.) may be disclosed to educational institutions named in your application.
  • Previous companies you worked for and reference check vendors.
    Your information (i.e. name) may be disclosed to your previous workplaces and reference check vendors.
  • Service providers.
    We may disclose your information to companies that provide Services on our behalf. These entities cannot use your information for purposes other than providing Services on our behalf.
  • Other parties when required by law or as necessary to protect our rights.
    There may be instances where we disclose your information to other parties:
    • - to comply with legal obligations or legally binding disclosure orders (such as a search warrant or other court/regulatory order);
    • - to verify or ensure compliance with the terms and policies governing our Services; and
    • - to protect the rights, property, or safety of us or any of our business partners or customers.
  • Other parties in connection with corporate transactions.
    We may disclose your information to a third party as part of a merger or transfer, or in the event of a bankruptcy.
  • Other parties with your consent or at your direction.
    In addition to the disclosures described in this Privacy Policy, we may disclose information about you to third parties when you consent to or request such disclosure.
Your Rights

To the extent permitted under applicable law(s), you may ask us to return, destroy, or correct any inaccuracies regarding your personal information. You may also ask us to restrict or limit our use of your personal information unless such restriction or limitation prevents us from complying with applicable law(s) or meeting a legal obligation.

However, your rights above may be limited in cases where your request would disclose personal information of a third party or where such a request would infringe the rights of a third party (including our rights) or if you ask us to delete information which we are required by law to preserve or have legitimate interests in retaining. Other relevant exemptions may exist under the GDPR and national laws. We will inform you of the relevant exemptions when responding to your request. To make such a request concerning your rights set forth herein, please refer to the Contact Us section below.

International Transfer of Information

We are a company based in Korea, and your use of our Website and Services will involve the transfer, storage, and processing of your personal information in Korea. Please note that the information protection laws and other applicable laws of countries outside the European Economic Area (“EEA”), to which your information may be transferred, might not be as comprehensive as those in your country. We will take appropriate measures, in compliance with applicable law, to ensure that your personal information remains protected. Such measures include the use of EU Standard Contractual Clauses to safeguard the transfer of information outside of the EEA or other methods. For more information, please contact us at privacy.bio@samsung.com.

Data Retention

We will retain your personal information for a reasonable period of time that enables us to communicate with you, to provide you with Services, to maintain business records for audit purposes, to meet recordkeeping requirements under applicable law(s), to defend or bring any legal claims and to deal with any queries or complaints you may have.

Keeping Your Information Secure

We have put in place reasonable measures to safeguard the information we collect in connection with the Services. However, please note that although reasonable steps will be taken to protect your information, no website, internet transmission, computer system or wireless connection is 100% secure from any and all potential threats.

Personal Information – Children under the age of 13

The Services are designed for general audience and are not intended or directed to children.

For US Residents Only

In connection with the Services, we will not knowingly solicit or collect personal information from children under the age of 13. In the event we do collect such personal information inadvertently or unknowingly and we later learn about it, we will promptly delete such information. If you believe that children under the age of 13 may have provided personal information to us, please contact us using the Contact Us section of this Privacy Policy.

If You are an individual resident in the EU

We process your personal information on the legal grounds that the processing is :

  • Necessary for the performance of contractual obligation(s) between you and us, for example if we’re providing service(s) that you have requested;
  • Necessary for compliance with our legal obligations;
  • Necessary for our legitimate interests, such as preparing our communications to you and continuing to develop and improve our services; or
  • With your consent or at your direction.

If you do not provide certain information to us, we may, in some circumstances, be unable to comply with our obligations or provide you with the services that you request. We will inform you of the implications of not providing certain information.

As set forth in the “Your rights” section, you are entitled, in accordance with applicable law, to object to or request restriction of processing your personal information, and to request access to, correction of, or deletion of your personal information. When we use your information on the basis of your consent, you have the right to withdraw such a consent at any time. Any requests should be submitted in writing to the address listed below in the “Contact Us” section. You also have the right to file a complaint with data protection authorities.

Contact Us

If you have any questions about this Privacy Policy, please contact us using the details below.

- Contact : 032-455-9829

- Email : privacy.bio@samsung.com

Changes to this Privacy Policy

We may update this Privacy Policy from time to time. When we update the Privacy Policy, we will revise the “Effective Date” above and post the new Privacy Policy with a new date. We recommend that you review the Privacy Policy each time you visit our Website to stay informed of our most current practices and policies.

close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION